Nexavar Medications
Nexavar News
Kidney Cancer Patients May Soon Have New Rx
Tivozanib phase III trial finds overall survival comparable to sorafenib
Never Too Late for Therapy
Lung cancer patients who are physically fit can still benefit from treatment
Drug Fails to Prolong Cancer Patient Lives
Lung cancer patients do not live longer with sorafenib
Kidney Cancer Drug Updates
Renal cell carcinoma phase III clinical trial data presented at ESMO
Tivozanib for Advanced Kidney Cancer
Advanced renal cell carcinoma responds well to investigational drug tivozanib
Kidney Cancer Rx Approved in Europe
Inlyta receives EU marketing authorization to treat advanced renal cell carcinoma
The Long and Winding Cancer Clinical Trial Road
Kidney cancer drugs battling it out in clinical trials
New Path to Fight Acute Myeloid Leukemia
Acute myeloid leukemia target found in CDK1 pathway
Kidney Cancer Takes a Direct Hit
Radioimmunotherapy disrupted by Nexavar
